|By PR Newswire||
|August 27, 2014 06:43 PM EDT||
LONDON, Aug. 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
The Pain Partnering 2009-2014 provides understanding and access to the pain partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of pain disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pain technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This data driven report contains over 400 links to online copies of actual pain deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
The initial chapters of this report provide an orientation of pain partnering trends.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in pain partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.
Chapter 3 provides an overview of the leading pain deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive directory of pain partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of pain technologies and products.
Pain Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to pain trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
Trends in pain dealmaking in the biopharma industry since 2009
Access to summary headline, upfront, milestone and royalty data
The leading pain deals by value since 2009
In Pain Partnering 2009-2014, the available deals are listed by:
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 1 – Introduction
Chapter 2 – Trends in pain partnering
2.2. Pain partnering over the years
2.3. Bigpharma pain dealmaking activity
2.4. Pain partnering by deal type
2.5. Pain partnering industry sector
2.6. Pain partnering by stage of development
2.7. Pain partnering by technology type
2.8. Disclosed financial deal terms for pain partnering
2.8.1 Pain headline values
2.8.2 Pain upfront payments
2.8.3 Pain milestone payments
2.8.4 Pain royalty rates
Chapter 3 – Leading pain deals
3.2. Top pain deals by value
3.3. Top pain deals involving bigpharma
Chapter 4 – Dealmaking directory
4.2. Company A-Z
4.3. By deal type
4.4. By industry sector
4.5. By stage of development
4.6. By technology type
Diagnostic - companion
In vitro models
Chapter 5 – Partnering resource center
5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking
Appendix 1 – Deal type definitions
About Wildwood Ventures
Recent titles from CurrentPartnering
Order Form – Reports
Table of figures
Figure 1: Pain partnering since 2009
Figure 2: Bigpharma – top 50 –pain deals 2009 to 2011
Figure 3: Bigpharma pain deal frequency – 2009 to 2011
Figure 4: Pain partnering by deal type since 2009
Figure 5: Pain partnering by industry sector since 2009
Figure 6: Pain partnering by stage of development since 2009
Figure 7: Pain partnering by technology type since 2009
Figure 8: Pain deals with a headline value
Figure 9: Pain deals with upfront payment values
Figure 10: Pain deals with milestone payments
Figure 11: Pain deals with royalty rates, %
Figure 12: Top pain deals by value since 2009
Figure 13: Top pain deals signed by bigpharma value since 2009
Figure 14: Online partnering resources
Figure 15: Forthcoming partnering events
Figure 16: Deal type definitions
Read the full report:
Pain Partnering 2009-2014
For more information:
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
Jan. 17, 2017 04:45 PM EST Reads: 3,027
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
Jan. 17, 2017 04:45 PM EST Reads: 539
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Jan. 17, 2017 04:45 PM EST Reads: 637
Jan. 17, 2017 04:30 PM EST Reads: 9,452
Jan. 17, 2017 04:30 PM EST Reads: 2,883
Jan. 17, 2017 04:15 PM EST Reads: 1,954
Jan. 17, 2017 03:30 PM EST Reads: 5,308
Jan. 17, 2017 03:26 PM EST Reads: 251
Jan. 17, 2017 02:45 PM EST Reads: 4,090
Jan. 17, 2017 02:30 PM EST Reads: 1,731
Jan. 17, 2017 02:15 PM EST Reads: 6,312
Jan. 17, 2017 02:15 PM EST Reads: 3,624
Jan. 17, 2017 02:15 PM EST Reads: 3,347
Jan. 17, 2017 02:00 PM EST Reads: 5,355
Jan. 17, 2017 02:00 PM EST Reads: 1,064